isospaglumic acid has been researched along with eglumetad in 2 studies
Studies (isospaglumic acid) | Trials (isospaglumic acid) | Recent Studies (post-2010) (isospaglumic acid) | Studies (eglumetad) | Trials (eglumetad) | Recent Studies (post-2010) (eglumetad) |
---|---|---|---|---|---|
469 | 31 | 116 | 190 | 5 | 48 |
Protein | Taxonomy | isospaglumic acid (IC50) | eglumetad (IC50) |
---|---|---|---|
Metabotropic glutamate receptor 2 | Homo sapiens (human) | 0.0063 | |
Metabotropic glutamate receptor 3 | Homo sapiens (human) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Neale, SA; Salt, TE | 1 |
Fujita, Y; Hashimoto, K; Slusher, BS; Takatsu, Y; Tsukamoto, T | 1 |
2 other study(ies) available for isospaglumic acid and eglumetad
Article | Year |
---|---|
Modulation of GABAergic inhibition in the rat superior colliculus by a presynaptic group II metabotropic glutamate receptor.
Topics: Animals; Bicuculline; Bridged Bicyclo Compounds; Dipeptides; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Neural Inhibition; Patch-Clamp Techniques; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Metabotropic Glutamate; Receptors, Presynaptic; Superior Colliculi; Synaptic Transmission; Time Factors; Visual Pathways | 2006 |
Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.
Topics: Administration, Oral; Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds; Dipeptides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Glutarates; Male; Mice; Neural Inhibition; Schizophrenia; Sensory Gating; Sulfhydryl Compounds; Xanthenes | 2011 |